Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer

被引：8
作者：
Liu, Ellen [1 ]
Guha, Avirup [2 ]
Bertino, Erin [3 ]
Franco, Veronica [2 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Internal Med, Div Cardiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Div Oncol, Columbus, OH 43210 USA
来源：
LUNG CANCER | 2017年 / 114卷
关键词：
RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL; MULTICENTER; MYOCARDITIS; DOCETAXEL;
D O I：
10.1016/j.lungcan.2017.07.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
[41]   Dual inhibition of BRAF and MEK in BRAF-mutated metastatic non-small cell lung cancer [J].
Kim, Young Hak .
JOURNAL OF THORACIC DISEASE, 2016, 8 (09) :2369-2371
[42]   Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib [J].
Dogan, Izzet ;
Khanmammadov, Nijat ;
Ahmed, Melin Aydan ;
Yildiz, Anil ;
Saip, Pinar ;
Aydiner, Adnan ;
Vatansever, Sezai .
CLINICAL CANCER INVESTIGATION JOURNAL, 2022, 11 (04) :5-9
[43]   The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors [J].
Nicos, Marcin ;
Krawczyk, Pawel ;
Crosetto, Nicola ;
Milanowski, Janusz .
FRONTIERS IN ONCOLOGY, 2020, 10
[44]   Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer [J].
Coffey, David G. ;
Xu, Yuexin ;
Towlerton, Andrea M. H. ;
Kowanetz, Marcin ;
Hegde, Priti ;
Darwish, Martine ;
Yadav, Mahesh ;
Blanchette, Craig ;
Ruppert, Shannon M. ;
Bertino, Sarah ;
Xu, Qikai ;
Ferretti, Andrew ;
Weinheimer, Adam ;
Hellmann, Matthew ;
Qin, Angel ;
Thomas, Dafydd ;
Warren, Edus H. ;
Ramnath, Nithya .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[45]   Immunotherapy for non-small cell lung cancer [J].
Vafadar, Sam .
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09) :37-42
[46]   Savolitinib for non-small cell lung cancer [J].
Zaborowska-Szmit, Magdalena ;
Szmit, Sebastian ;
Krzakowski, Maciej ;
Kowalski, Dariusz M. .
DRUGS OF TODAY, 2023, 59 (01) :17-36
[47]   Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review [J].
Ogawa, Koichi ;
Kaneda, Hiroyasu ;
Kawamoto, Tamaki ;
Tani, Yoko ;
Izumi, Motohiro ;
Matsumoto, Yoshiya ;
Sawa, Kenji ;
Suzumura, Tomohiro ;
Watanabe, Tetsuya ;
Mitsuoka, Shigeki ;
Asai, Kazuhisa ;
Kawaguchi, Tomoya .
INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) :1901-1905
[48]   Immune checkpoint inhibitors in non-small cell lung cancer [J].
Eberhardt, Wilfried Ernst Erich .
ONKOLOGE, 2017, 23 (10) :838-844
[49]   Drug treatment of metastasized non-small cell lung cancer [J].
Leipert, Jenny ;
Hammerschmidt, Stefan ;
Gessner, Christian .
PNEUMOLOGE, 2019, 16 (06) :397-409
[50]   New advances in immunotherapy for non-small cell lung cancer [J].
Qin, Haifeng ;
Wang, Fang ;
Liu, Hui ;
Zeng, Zhen ;
Wang, Shasha ;
Pan, Xin ;
Gao, Hongjun .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08) :2234-2245
12345